‪Rajeev Kumar Sahoo‬ - ‪Google Scholar‬

Get my own profile

Cited by

	All	Since 2019
Citations	11	11
h-index	2	2
i10-index	0	0

0

6

3

2022202320241 4 6

Public access

0 articles

1 article

available

not available

Based on funding mandates

Co-authors

Bijesh K BiswalDepartment of Life Science, National Institute of Technology Rourkela, Odisha,IndiaVerified email at nitrkl.ac.in
Surya Kant TripathiPostdoctoral Research Associate at University of North Carolina Chapel Hill USAVerified email at email.unc.edu
Munmun PandaAssistant professor in Botany, AIPH UniversityVerified email at nitrkl.ac.in

Rajeev Kumar Sahoo

Rajeev Kumar Sahoo

Researcher at National Institute of Technology Rourkela

Verified email at nitrkl.ac.in

Cancer Biology Cancer Drug Resistance


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance SK Tripathi, RK Sahoo, BK Biswal Drug Discovery Today 27 (9), 2541-2550, 2022	6	2022
Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer S Biswal, M Panda, RK Sahoo, SK Tripathi, BK Biswal Archives of Oral Biology, 105697, 2023	4	2023
Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics. RK Sahoo, SK Tripathi, S Biswal, M Panda, SS Mathapati, BK Biswal Biotechnology Journal 19 (2), e2300370-e2300370, 2024	1	2024
Enigmatic exosomal connection in lung cancer drug resistance SK Patra, RK Sahoo, S Biswal, SS Panda, BK Biswal Molecular Therapy-Nucleic Acids, 2024		2024
Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer … SK Tripathi, RK Sahoo, BK Biswal Naunyn-Schmiedeberg's Archives of Pharmacology, 1-17, 2024		2024

The system can't perform the operation now. Try again later.

Articles 1–5